We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+4.67%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$7.05B
AUM Growth
+$276M
(+4.1%)
Cap. Flow
+$73M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
27.96%
Holding
1,430
New
433
Increased
334
Reduced
305
Closed
319
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$182M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$170M |
| 3 |
AET
Aetna Inc
AET
|
+$131M |
| 4 |
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
|
+$108M |
| 5 |
Brookdale Senior Living
BKD
|
+$91.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$435M |
| 2 |
Elevance Health
ELV
|
+$121M |
| 3 |
Cigna
CI
|
+$119M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$82.7M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$72.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 49.34% |
| 2 | Financials | 7.86% |
| 3 | Consumer Discretionary | 7.17% |
| 4 | Technology | 6.32% |
| 5 | Industrials | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
751
Novartis
NVS
$297B
| $327K | ﹤0.01% |
+3,712
| New | +$341K |
|
|
GRUB
752
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $327K | ﹤0.01% |
4,800
+1,650
| +52% | +$134K |
|
|
SFG
753
DELISTED
STANCORP FINL GRP
SFG
| $326K | ﹤0.01% |
+4,307
| New | +$317K |
|
754
Abbott
ABT
$183B
| $325K | ﹤0.01% |
6,614
-17,440
| -73% | -$837K |
|
755
DigitalBridge
DBRG
$2.93B
| $325K | ﹤0.01% |
+4,400
| New | +$374K |
|
|
DATA
756
DELISTED
Tableau Software, Inc.
DATA
| $324K | ﹤0.01% |
+2,809
| New | +$304K |
|
757
Progressive
PGR
$123B
| $322K | ﹤0.01% |
11,584
+4,184
| +57% | +$114K |
|
|
MITL
758
DELISTED
Mitel Networks Corporation
MITL
| $322K | ﹤0.01% |
+36,518
| New | +$340K |
|
|
ILG
759
DELISTED
ILG, Inc Common Stock
ILG
| $322K | ﹤0.01% |
+14,088
| New | +$356K |
|
760
Vulcan Materials
VMC
$34.8B
| $321K | ﹤0.01% |
3,830
-123,170
| -97% | -$10.7M |
|
|
SVU
761
DELISTED
SUPERVALU Inc.
SVU
| $320K | ﹤0.01% |
5,642
+2,237
| +66% | +$149K |
|
762
ITT
ITT
$17.5B
| $319K | ﹤0.01% |
7,628
-802
| -10% | -$33.4K |
|
763
OneMain Financial
OMF
$7.2B
| $319K | ﹤0.01% |
+6,938
| New | +$337K |
|
|
SRCL
764
DELISTED
Stericycle Inc
SRCL
| $319K | ﹤0.01% |
+2,382
| New | +$327K |
|
|
PLCM
765
DELISTED
POLYCOM INC
PLCM
| $319K | ﹤0.01% |
27,874
+13,353
| +92% | +$174K |
|
766
Nike
NKE
$61.9B
| $318K | ﹤0.01% |
5,894
+894
| +18% | +$45.8K |
|
767
Tapestry
TPR
$30.8B
| $318K | ﹤0.01% |
9,174
+237
| +3% | +$9.06K |
|
|
MDRX
768
DELISTED
Veradigm Inc. Common Stock
MDRX
| $318K | ﹤0.01% |
23,224
-2,194,330
| -99% | -$29.6M |
|
769
First Solar
FSLR
$22.7B
| $317K | ﹤0.01% |
6,740
-916
| -12% | -$51.2K |
|
770
Omega Healthcare
OHI
$15.1B
| $316K | ﹤0.01% |
+9,214
| New | +$338K |
|
771
Paychex
PAYX
$41.6B
| $316K | ﹤0.01% |
6,750
-593
| -8% | -$29K |
|
772
Assured Guaranty
AGO
$3.66B
| $314K | ﹤0.01% |
+13,102
| New | +$365K |
|
773
Avient
AVNT
$3.33B
| $313K | ﹤0.01% |
7,993
-4,623
| -37% | -$181K |
|
774
Kimberly-Clark
KMB
$36.3B
| $313K | ﹤0.01% |
2,954
-3,752
| -56% | -$409K |
|
775
Synaptics
SYNA
$4.19B
| $312K | ﹤0.01% |
+3,600
| New | +$329K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q2 2015 Portfolio in Review
As of Q2 2015, Visium Asset Management held 1,430 positions worth $7.05B, up 4.1% from $6.78B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Visium Asset Management's Q2 2015 filing shows 433 new, 334 increased, 305 reduced and 319 closed positions. Its largest new stake was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M. The largest sale was Allergan plc, an estimated $435M.
By sector, the portfolio is most concentrated in Healthcare at 49% of assets, down from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
- Visium Asset Management's largest Q2 2015 buy was Sio Gene Therapies Inc. Common Stock: 635,000 shares worth $104M.
- Visium Asset Management added most to Bausch Health in Q2 2015, an estimated $182M increase.
- Visium Asset Management's biggest Q2 2015 reduction was Elevance Health, cutting an estimated $121M.
- Visium Asset Management fully exited Allergan plc in Q2 2015, selling an estimated $435M.
- Visium Asset Management's ten largest holdings make up 28% of its $7.05B portfolio in Q2 2015.
- Visium Asset Management opened 433 new positions and closed 319 in Q2 2015.
- Visium Asset Management's portfolio value rose 4.1% quarter-over-quarter to $7.05B.
Based on Visium Asset Management's 13F filing for Q2 2015, filed 14 Aug 2015.